Azelis Group NV

Brussels Stock Exchange AZE.BR

Azelis Group NV EBITDA Margin for the year ending December 31, 2023: 11.32%

Azelis Group NV EBITDA Margin is 11.32% for the year ending December 31, 2023, a 3.39% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Azelis Group NV EBITDA Margin for the year ending December 31, 2022 was 10.95%, a 29.31% change year over year.
Azelis Group NV EBITDA Margin for the year ending December 31, 2021 was 8.47%, a 0.65% change year over year.
Azelis Group NV EBITDA Margin for the year ending December 31, 2020 was 8.42%, a 2.17% change year over year.
Azelis Group NV EBITDA Margin for the year ending December 31, 2019 was 8.24%, a 373.33% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Brussels Stock Exchange: AZE.BR

Azelis Group NV

CEO	Ms. Anna Bertona
IPO Date	Sept. 17, 2021
Location	Belgium
Headquarters	Posthofbrug 12
Employees	3,481
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Petrochemicals

Description

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients in Belgium and internationally. It serves various segments in life sciences, including personal care, pharma, food and health, specialty agri/horti, and homecare and industrial chemicals; and industrial chemicals industry, such as CASE, rubber and plastic additives, lubricants and metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper applications. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium. Azelis Group NV operates as a subsidiary of Akita I S.À R.L.

Key trends

Past 5 years